Analytical testing will accelerate Numinus Research and Development capabilities and generate revenue through third-party clients Numinus Wellness Inc. a leader in psychedelics-focused mental healthcare, has today announced novel, proprietary methods for psychedelic mushroom compound screening. The testing, which was developed and validated in-house, will be available as part of its service offerings for .